MedTrace Logo

Harm Reduction Intervention for Anabolic-androgenic Steroids Users: a Randomized Controlled Trial

NCT07039539 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-05-18

No results posted yet for this study

Summary

This clinical trial aims to investigate the short and long-term efficacy of a harm reduction intervention in reducing the use of non-clinical anabolic-androgenic steroids (AAS) in abusive users of AAS. As secondary objectives, the study will investigate the intervention's effect on health parameters (i.e., blood), quality of life, sleep quality, body image, eating behavior, depression, anxiety, fatigue, aggressiveness, cardiovascular parameters, muscle strength, body composition and muscle cross-sectional area outcomes.

Conditions

  • Drug Abuse
  • Harm Reduction
  • Minimization, Harm
  • Anabolic Steroids Adverse Events
  • Brief Intervention

Interventions

BEHAVIORAL

harm reduction intervention in non-clinical anabolic-androgenic steroids users

Participants will receive four structured counseling sessions, each lasting up to 30 minutes. Utilizing a non-judgmental harm reduction framework, these sessions aim to reduce substance abuse and address associated health risks. The intervention is person-centered, tailoring discussions to the user's specific needs and questions regarding their health and the use of non-clinical anabolic-androgenic steroids (AAS).

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2027-12-30
Completion
2027-12-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07039539 on ClinicalTrials.gov